Vito Longo
- Oncology top 10%
- Lung Cancer Research Studies 12
- Cancer Immunotherapy and Biomarkers 9
- Peptidase Inhibition and Analysis 4
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Cancer Genomics and Diagnostics 4
-
- Lung Cancer Treatments and Mutations 6
-
- Neuroendocrine Tumor Research Advances 9
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Oronzo BrunettiDomenico GalettaAntonio Giovanni SolimandoAntonella LicchettaAntonio GnoniAntonella ArgentieroAnnamaria CatinoSabina Delcuratolo
- Cited by
- OncologyHepatologyCancer Research
- Partner nations
- ItalyCzechiaUnited Kingdom
In The Last Decade
Vito Longo
25 papers receiving 484 citations
Peers
Comparison fields: 5 of 60
- Oncology 284
- Hepatology 82
- Cancer Research 94
- Immunology 95
- Pulmonary and Respiratory Medicine 128
Countries citing papers authored by Vito Longo
This map shows the geographic impact of Vito Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Longo more than expected).
Fields of papers citing papers by Vito Longo
This network shows the impact of papers produced by Vito Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Longo. The network helps show where Vito Longo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vito Longo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 35 | |
| 13 | 2021 | 0 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 46 | |
| 16 | 2020 | 43 | |
| 17 | 2019 | 54 | |
| 18 | 2019 | 59 | |
| 19 | 2019 | 51 | |
| 20 | 2018 | 1 |
About Vito Longo
Vito Longo is a scholar working on Oncology, Hepatology and Cancer Research, having authored 29 papers that have together received 487 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Mechanisms and Therapy (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Genomics and Diagnostics (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (284 citations), Hepatology (82 citations) and Cancer Research (94 citations). Vito Longo has collaborated with scholars based in Italy, Czechia and United Kingdom. Frequent co-authors include Oronzo Brunetti, Domenico Galetta, Antonio Giovanni Solimando, Antonella Licchetta, Antonio Gnoni, Antonella Argentiero, Annamaria Catino, Sabina Delcuratolo, Nicola Silvestris and Pamela Pizzutilo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.